DE68913212D1 - Ein reines faktor i-protein und verfahren zur herstellung. - Google Patents

Ein reines faktor i-protein und verfahren zur herstellung.

Info

Publication number
DE68913212D1
DE68913212D1 DE90900763T DE68913212T DE68913212D1 DE 68913212 D1 DE68913212 D1 DE 68913212D1 DE 90900763 T DE90900763 T DE 90900763T DE 68913212 T DE68913212 T DE 68913212T DE 68913212 D1 DE68913212 D1 DE 68913212D1
Authority
DE
Germany
Prior art keywords
protein
factor
pct
date
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90900763T
Other languages
English (en)
Other versions
DE68913212T2 (de
Inventor
E Karina Als
Jesper Kihl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of DE68913212D1 publication Critical patent/DE68913212D1/de
Publication of DE68913212T2 publication Critical patent/DE68913212T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE68913212T 1988-12-20 1989-12-19 Ein reines faktor i-protein und verfahren zur herstellung. Expired - Fee Related DE68913212T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat
PCT/DK1989/000297 WO1990006759A1 (en) 1988-12-20 1989-12-19 A pure factor i protein and a process for producing said protein

Publications (2)

Publication Number Publication Date
DE68913212D1 true DE68913212D1 (de) 1994-03-24
DE68913212T2 DE68913212T2 (de) 1994-05-19

Family

ID=8149208

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68913212T Expired - Fee Related DE68913212T2 (de) 1988-12-20 1989-12-19 Ein reines faktor i-protein und verfahren zur herstellung.

Country Status (11)

Country Link
US (1) US5378811A (de)
EP (1) EP0449897B1 (de)
JP (1) JPH04502324A (de)
AT (1) ATE101521T1 (de)
AU (1) AU4811290A (de)
DE (1) DE68913212T2 (de)
DK (2) DK708488D0 (de)
ES (1) ES2062502T3 (de)
FI (1) FI95440C (de)
NO (1) NO912387D0 (de)
WO (1) WO1990006759A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
EP1107807B1 (de) * 1998-08-25 2006-10-11 Ash Access Technology, Inc. Verwendung von citrat in einer kathetersperrlösung
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
GB0904427D0 (en) * 2009-03-13 2009-04-29 Lachmann Peter Treatment of diseases related to hyperactivity of the complement system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤

Also Published As

Publication number Publication date
ES2062502T3 (es) 1994-12-16
AU4811290A (en) 1990-07-10
NO912387L (no) 1991-06-19
WO1990006759A1 (en) 1990-06-28
FI95440B (fi) 1995-10-31
DK105391A (da) 1991-06-03
EP0449897A1 (de) 1991-10-09
FI95440C (fi) 1996-02-12
DE68913212T2 (de) 1994-05-19
DK708488D0 (da) 1988-12-20
FI912879A0 (fi) 1991-06-14
EP0449897B1 (de) 1994-02-16
JPH04502324A (ja) 1992-04-23
ATE101521T1 (de) 1994-03-15
NO912387D0 (no) 1991-06-19
DK105391D0 (da) 1991-06-03
US5378811A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
DE69727595D1 (de) Verfahren zur herstellung eines extraktes des plättchenwachstumsfaktors für zubereitungen zur wundheilung
HUP9900920A2 (hu) Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
FI912104A0 (fi) Neurotrofisk faktor haerledd fraon hjaerna.
LV10308A (lv) Ciliarais neirotropais faktors
ATE87003T1 (de) Oligosaccharide, immunogene und impstoffe und verfahren zur herstellung dieser oligosaccharide, immunogene und impstoffe.
DE69115218D1 (de) Verfahren und System zur Herstellung von medizinischen Lösungen, insbesondere zur Dialyselösung.
ATE167232T1 (de) Protein mit knochenbildungs-eigenschaften und verfahren zu seiner herstellung
DE3769096D1 (de) Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion.
ATE3045T1 (de) Verfahren zur reinigung und konzentrierung des faktor-viii-komplexes.
ATE207933T1 (de) Verfahren zur herstellung vom aktieven protein dimerischen
DE68913212D1 (de) Ein reines faktor i-protein und verfahren zur herstellung.
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE69328102D1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
ATE31733T1 (de) Verfahren zur herstellung von hybridisierungssonden.
ATE215784T1 (de) Verfahren zur herstellung eines kappa-casein- glykomakropeptides oder eines abkoemmlings davon
ATE27822T1 (de) Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus.
DE3775684D1 (de) Verfahren zur herstellung von derivaten phosphinischer saeure und zwischenprodukte dafuer.
ATE13633T1 (de) Verfahren zur herstellung von hochgereinigtem antihaemophiliefaktor.
ATE32066T1 (de) Antihypertensive 3-aryl-1,2-benzisoxazolsulfonyl und -sulfinyl-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
MX9800686A (es) Nueva proteina hmw humana mp52s.
DE69122545T2 (de) Verfahren zur Herstellung von menschlichem Nervenwachstumsfaktor durch Genmanipulation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee